View in EDS HTML Full Text PDF Full Text

Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.

Saved in:
Bibliographic Details
Title: Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
Authors: Agarwal SM; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.; Temerty Faculty Institute of Medical Science, University of Toronto, Toronto, Canada.; Department of Psychiatry, University of Toronto, Toronto, Canada.; Banting and Best Diabetes Centre (BBDC), University of Toronto, Toronto, Canada., Dissanayake J; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Agid O; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Bowie C; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Brierley N; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Chintoh A; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., De Luca V; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Diaconescu A; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Gerretsen P; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Graff-Guerrero A; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Hawco C; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Herman Y; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Hill S; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Hum K; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Husain MO; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Kennedy JL; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Kiang M; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Kidd S; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Kozloff N; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Maslej M; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Mueller DJ; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Naeem F; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Neufeld N; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Remington G; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Rotenberg M; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Selby P; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Siddiqui I; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Szacun-Shimizu K; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Tiwari AK; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Thirunavukkarasu S; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Wang W; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Yu J; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Zai CC; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Zipursky R; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada., Hahn M; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.; Temerty Faculty Institute of Medical Science, University of Toronto, Toronto, Canada.; Department of Psychiatry, University of Toronto, Toronto, Canada.; Banting and Best Diabetes Centre (BBDC), University of Toronto, Toronto, Canada., Foussias G; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.; Temerty Faculty Institute of Medical Science, University of Toronto, Toronto, Canada.; Department of Psychiatry, University of Toronto, Toronto, Canada.
Source: PloS one [PLoS One] 2023 Sep 21; Vol. 18 (9), pp. e0288354. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0288354